Introduction
The oral lesions associated to human immunodeficiency virus infection represent an important problem in the HIV+ population, being predictive of the disease progression (1) . Several studies have been done to establish the prevalence of the oral lesions associated to the disease, related with age, gender, tobacco, CD4 cell count and viral load (2, 3) . Preliminary investigations conducted in Venezuela (4) demonstrated that oral candidiasis was the most frequent opportunistic infection, followed by oral hairy leukoplakia and melanic hiperpigmentation, observing a high viral load associated to these oral lesions presence but independently of the CD4+ count. Oral hairy leukoplakia (OHL) is related to EBV infection characterized by a viral replication within the epithelium of the lateral border of the tongue (5) . Clinically presents as a white oral lesion and has been considered as an early indicator of HIV infection as well as a progression marker of the disease. Therefore, it of outmost importance to establish an early diagnosis. OHL has been mainly related to severe immunodeficiency similar to the HIV infection, malignant tumors and organ transplanted patients (7) . However, OHL has also been reported in patients with moderate or minor immunodeficiency and immunocompetent individuals (8) . EBV is a member of the Herpesviridae family, gammaherpesviridae subfamily infecting lymphocytes and epithelial cells. Previous EBV seroprevalence studies have indicated that more than 90% of the world population has antibodies against EBV, being the etiologic factor in malignant diseases such as Burkitt´s Lymphoma and Nasopharyngeal carcinoma, mainly characterized by EBV latent infection and cellular proliferation (5) . The clinical and histopathologic OHL features are not enough for the final diagnosis, the EBV presence is required to fulfill the diagnostic definitive criteria (9) . The virus could be detected by LMP-1 expression using immunohistochemistry or using Nested PCR detecting the viral DNA (10) . The latent membrane protein 1 (LMP-1) is considered the principal EBV oncoprotein, its expression is required for the EBV latent infection and B cell transformation (10) . With the antiretroviral therapy use in HIV/AIDS, the opportunistic infections have declined due to the use of antiretroviral therapy leading to a better quality of patient life (11) . The aim of the present study was to determine the prevalence of Epstein Barr virus (EBV) in oral hairy leukoplakia lesions (OHL) in HIV+ venezuelan patients.
Materials and Methods
We evaluated in this cases study, 21 HIV+ adult patients with clinically present OHL lesions, 11 with antiretroviral therapy, 10 without therapy and 10 HIV negative adult patients with hiperkeratotic oral mucosal lesions. All of them were assessed at the Infectious Disease Center, Faculty of Dentistry, Central University of Venezuela and clinically examined to detect oral mucosal lesions present and establish the histopathologic diagnosis. Nested-PCR was used to determine the EBV infection and the LMP-1 expression by immunohistochemistry. In the present study, patiens with white oral lesions previously diagnosed as oral lichen planus were excluded. Clinical evaluation was conducted by the same examiner, an oral medicine practitioner following the Clearinghouse criteria of diagnosis (12) data was collected in a chart designed for this purpose. All the included patients with clinically present oral white lesions followed the diagnostic criteria reported by Axell et al. (13) and all signed a written informed consent to participate in the study. Incisional biopsies were taken from patients with oral lesions divided in two fragments, one for the histopathologic and immunohistochemical diagnosis and the other one was frozen in -70°C for the molecular analysis by nested PCR. Prior to DNA extraction the samples were centrifugated to 100 x g, 10 minutes 4°C, the pellet was resuspended in 1 PBS ml and centrifugated to 1000 x g, by one minute. Peripheral blood samples (5cc) were obtained from HIV+ patients, posterior to the oral clinical examination to determine the cell count using flow citometry and the viral load by RT-PCR (Amplicor HIV-1 test TM kit, Roche), considering a low viral load between 401-5000 copies / mm3, moderate 5001 -30.000 copies / mm3 and high > 30.000 copies / mm3 Nested PCR: We obtained DNA from fresh biopsy samples, resuspended in digested buffer and proteinase K 1000 µg/ ml and 100 µl de buffer lysis (100 mM of Tris-HCl, pH 8 and 0,1% sarcosin) were incubated overnight. Posteriorly, inactivation of proteinase K was done at 95° for 5 min and followed by phenol-chloroform extraction and ethanol precipitation). The pellet was resuspended in 100 µl of TE buffer (10mM), Tris-HCl 0,1M pH 7,4; 0,1mM EDTA pH 8,0 by 20 h at 37°C. The samples were kept at -20°C. 5 µl of aqueous phase were used for PCR. To increase the sensitivity of EBV detection, nested PCR assay were apply, using W1-W2 (W1: 5´CTA GGG GAG AAC GTG AA 3´) and (W2: 5´ CTG AAG GTG AAC CGC TTA CCA 3´) as the outer and W3-W4 as the inner EBV-primers (W3: 5´ GGT ATC GGG CCA GAG GTA AGT 3´), and (W4: 5´ GCT GGA CGA GGA CCC TTC TAC 3´). The inner primers amplify a 192-bp within the sequence amplified by the outer primers. 25-µl reaction mixture consisted of 1 µM of each primer, 1 µg of the extracted sample, 1 X Taq Buffer (100 mM Tris-HCl, pH 8.3, 500 mM KCl, 11 mM MgCl2 and 0.1% gelatin), 200 µM of each dNTPs and 1 unit of Taq DNA Polymerase were used. Initial denaturation occurred at 94°C for 4 min, followed by 30 cycles: 45s at 92°C, 30s at 66°C, 45s at 72°C. A final extension was done at 72°C for 5 min. For negative control water replaced the DNA target. DNA samples were reamplified in a nested PCR using a W3-W4 primers. We used the same amplification parameters for 40 cycles, using a 2 µL template from the first step amplification products. Subsequently, 10 µl of the PCR reaction mixture were electrophoresed in a 3% agarose gel containing 0.5 µg/ mL ethidium bromide and visualized under an ultraviolet transilluminator. A positive sample was considered when a 192 bp band was observed corresponded to EBV amplification.
Expression of EBV LMP-1 by immunohistochemistry:
The EBV (lmp-1) expression was done by immunohistochemistry following the standarized protocol. 3µ sections were obtained from each paraffin block, deparaffinated and antigenically retrieved using tripsyn 37°C (30 minutes) and endogeneous peroxidase was blocked with methanol H202 (20 minutes).The sections were incubated with Anti EBV monoclonal antibody (LMP clone CS-1-4, Dako, USA), diluted 1:50 for 45 minutes. The envision detection system was used for 20 minutes using diaminobenzidine (DAKO) to visualize the reaction and counterstained with Meyer hematoxylin. The statistical analysis was done using the SPSS (13.0 version) and the Chi Square non parametrical test.
Results
Twenty-one HIV + adult patients with OHL were evaluated, 20 were males (95%) and only one female (5%), between 21 and 60 years of age (45.5 ± 12.3). In addition, 10 patients HIV-with oral mucosal hyperkeratosis were studied, 6 of them were males (60%) and 4 were females (40%), age ranging between 21 and 70 years with an average (51.94 ± 16.8).
Regarding the sexual behavior in the HIV + group, there was a predilection in men who had sex with men 20/21 (95%), and just one patient was heterosexual, while in the HIV -group all patients were heterosexual (Table  1a , 1b) In relation with the anatomical location and the presence of OHL, we observed 9/21 (43%) had lesions at left border of the tongue, 10/21 (47 %) in right lateral border of the tongue, 1/21 in both lateral borders of the tongue and buccal mucosa respectively. In the HIV-patients with oral hyperkeratosis, we observed the lesions at the buccal mucosa sulcus in 3/10 patients (30%), 1 /10 cases at right side, 4/10 (40%) in both sides and 2/10 (20%) at buccal mucosa and the tongue. Related to the habits, 11/21 EBV + patients were tobacco users and 10/21 were non smokers, however in the EBV-/HIV-8/10 (80%) were smokers and 2/10 (2%) were non smokers. These results were statistical significant (p<0.05). In addition, the HIV+ patients 6/21 (29%) were alcohol users and 15/21 (71%) were non consumers, while in the HIV-patients, 4/10 (40%) consumed alcohol and 6/10 (60%) were not. Regarding the presence of OHL /VEB + patients, we found 14/21 (66%) of them presented a viral load <400.000 copies RNA / ml while only 2/21 (10%) presented high viral load >400.000 copies RNA /ml. The EBV-/OHL patients, 5/21 (24%) had low viral load. According to CD4+ T cell count in OHL/EBV+, we evidenced that 5/21 (24%) had a cell count between 100-300 cells/ mm The EBV lmp-1 expression demonstrated nuclear positivity in 13/ 21 (62%) of the cases. The immunolocalization was in the keratinocytes in 2/13 (15%) and in 11/13 (84.6%) in the basal cell layer. Additionally, 4/13 evidenced immunopositivity in the spinous cell layer. The intensity of the immunoreaction was low in 14%, moderate in 29% and strong in 19% of the cases (Fig. 2) . The extension of the immunostaining was 30-60 positive cells (19%) and 60-100 (33%) of the cases. 
Discussion
OHL represents a relatively frequent condition among HIV+ patients associated with EBV infection. Its occurrence has a prognostic value, therefore it is considered an immunodeficiency marker especially in HIV (+) with 10% of the individuals presenting AIDS at the moment of the diagnosis and 20% could developed it in the following eight months. Previous studies have documented the OHL presence in moderate or mild immunodeficiency as well as in immunocompetent, in pregnant women and in diabetes mellitus patients (8) . Additionally a positive correlation exits between the OHL prevalence and decrease of the CD4 T cell count (12%).
In the present investigation, we detected the EBV lmp 1 expression in OHL in a group of HIV + and HIV -venezuelan patients. The distribution of the studied population according to gender and age group demonstrated a 95% of the OHL/ HIV + corresponded to males while a 5% were females, between 21 and 60 years. These results are in contrast to other investigations (16) where females were more affected and in agreement with other authors reporting OHL was predominantly in males (17) . These higher prevalence in males could be due to the sexual behavior, men who had sex with men that represents 95% in the present study in concordance with other reports (16) .
Regarding the distribution of OHL according to age we observed a similar range between HIV+ and HIV-patients.
The OHL clinical features in the present work are similar to previous reports from the literature, with white non removable lesions located at the lateral borders of the tongue, with unilateral or bilateral presentation, with a corrugated smooth or hairy surface. OHL usually appears in HIV+ patients with severe immunodeficiency (18) . The most frequent OHL anatomical location is lateral borders of the tongue, however eventually could appear at ventral aspect of the tongue, floor of the mouth, soft palate and buccal mucosa (19) , in agreement with the present study results where 5% of the evaluated patients presented the entity at right or left buccal mucosa.
In the present investigation we detected a high percentage of EBV positive patients (76%) by nested PCR, in agreement with other studies demonstrating EBV in OHL (8) . Several studies have indicated that OHL/EBV is determined by the expression of multiple viral genetic products leading to infection and subsequent cell transformation, therefore contributing to the pathogenesis. The OHL spinous cell layer expressed viral latent and lytic proteins with a critical role in the development of the lesion (19) . In contrast to herpesviruses where a fulminant replication occurs resulting in cellular lysis and ulcer formation, EBV/OHL may cause acanthosis probably induced by cellular proliferation to reassure the cell survillance within the lesion. These transforming proteins originated an optimal environment for viral replication and the subsequent cell infection (19) . Recently, Bagan et al. (20) reported the EBV infection in oral squamous cell carcinoma and verrucous proliferative leukoplakia. The molecular diagnosis using nested PCR is of highly sensitivity and specificity to detect low number of viral particles, that probably is the existent condition in this disease.
According to antiretroviral therapy in HIV+ patients, some authors have reported that it could not influence the disappareance of the disease (11), concordant with the present investigation results with a 38 % of the EBV positive patients under therapy. It is noteworthy that these patients were under simple antiretroviral treatment and a 38% were not under therapy indicating that the treatment did not influence the appearance of the lesion.
In the present study, there was not association between tobacco use and the presence of OHL. However, there are studies indicating a positive relation among smokers and OHL (2) . On the other hand, in the case of HIV-, the majority were smokers. Alcohol use was not associated to OHL in the present investigation. In relation to viral load and EBV, our results demonstrated that a 66% of the EBV + individuals have a low viral load and 24% of EBV-presented a high viral load, concluding that there was not relation between viral load of the patient and EBV infection. Similar results were observed with the CD4+ T cell count in the HIV+/ OHL, where no association was observed. The EBV lmp 1 in HIV+/EBV+ /OHL patients was highly expressed (84.6 %) especially at the basal cells. In a preliminary study conducted in Venezuela, EBV lmp1 was detected in all HIV+ patients with the diagnosis of diffuse lymphocytic infiltrative syndrome (DILS) in minor salivary glands (10) where EBV positivity was marked in contrast to cytomegalovirus expression. The differences of the lmp 1 expression in both studies could be due to the viral replication localization. In OHl it was observed at the epithelial basal cell while in the DILS was prominent at ductal epithelial cells.
